Local Events

1-14-2015 - Glastonbury, CT - Dinner Conference

****************************

1-30-2015 - Narragansett, RI - Knock Out Parkinson's Event

***************************

2-10-2015 - Lincoln, RI - Lunch & Learn

***************************

2-20-2015 - Newington, CT - Lunch & Learn

***************************

2-27-2015 - Putnam, CT - Lunch & Learn

**************************

2-28-2015 - Tulsa, OK - 4th Annual Music Trivia Charity Event

*************************

3-7-2015 - Madison, WI - Wine Tasting Benefit

*************************

3-16-2015 - Woodbury, CT - Lunch & Learn

*************************

3-18-2015 - Glastonbury, CT - Dinner Conference

*************************

4-11-2015 - Rolling Meadows, IL - Educational Symposium

*************************

4-11-2015 - Virginia Beach, VA - Optimism Walk

*************************

4-12-2015 - Delray Beach, FL - Optimism Walk

***********************

4-18-2015 - Cottage Grove, WI - Half Marathon/5k

***********************

4-25-2015 - Mason, OH  - Spring Educational Forum

***********************

5-4-2015 - Stone Mountain, GA - Liberty Mutual Invitational Golf Tournament

************************

9-12-2015 - Naperville, IL (Chicago) - Optimism Walk

 




 

 
Purchase Your Copy Today!
 
In Both Sides Now: A Journey from Researcher to Patient, Dr. Alice Lazzarini realizes the unthinkable – she is developing symptoms of the very disease she spent years researching: Parkinson’s.
This inspiring memoir will make you laugh, cry and cheer as Dr. Lazzarini embarks on a journey of self-discovery, and experiences the race toward the development of new treatments with an additional sense of urgency.
 
 
You can check out Dr. Lazzarini's Blog -
Neurogenetic Journey - a view from both sides of the white coat -
at Psychology Today

 


 

 
Your support today will bring Optimism to more than 1 million individuals and families impacted by Parkinson's disease.
 

 



Parkinson's researcher learning to live with the disease

MENDHAM – Parkinson's disease has pervaded
Alice Lazzarini's life. ... leads to the
formation of Lewy bodies—the hallmark of
Parkinson's disease. (read more)


 

 

First Steps Towards a Vaccine for Parkinson's disease

by Alice Lazzarini, PhD

On July 31st, the Austrian biotech company, AFFiRiS AG announced the results of an early-stage trial of a vaccine intended to treat Parkinson’s disease. This is the first such study in Parkinson’s, although there has been work with similar strategies in Alzheimer disease.

Read more here
 


 

Meet APDA’s Research Grant Awardees 

APDA’s Scientific Advisory Board has selected 11 grant applications (seven research grants and four post-doctoral fellowships) and the Board of Directors approved for funding in 2014/15 APDA is pleased to present a synopsis of this year’s awards to support scientists whose research promises new insights into the disease. Such support has historically enabled recipients to position their work to a level eligible for greater funding. APDA has been a funding partner in most of the major PD scientific breakthroughs. 


Stanford University

Project Title: Defining the role of microglia-specific
LRRK2 in Parkinson’s disease.





 

US Neurology and European Neurological Review enables time-pressured physicians to stay abreast of key advances and opinion in neurological practice in the US and Europe. The journals comprise balanced and comprehensive articles written by leading authorities addressing the most important and salient developments in the neurological field. 
 

VIEW ALL

READ THE LATEST NEWS

image description

Scripps Florida scientists establish that drug candidates can block pathway associated with cell death in Parkinson's disease

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction...

Continue reading this article . . .
image description

Scientists find drug candidates can block cell-death pathway associated with Parkinson's

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction...

Continue reading this article . . .